Search

everythinglearnresearchcommunity

for

Search:↓

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

The timing of when the gene Bmal1 is active affects aging and survival, with its absence during development, not adulthood, leading to premature aging.

The skin is a complex barrier for drug penetration, but understanding its structure and interactions can improve drug delivery methods.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Nanoparticles can improve skin drug delivery but have challenges like toxicity and stability that need more research.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Oral retinoids are effective for severe skin conditions but require careful use due to side effects.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

The new dutasteride formula can be applied to the skin, may promote hair growth, and has fewer side effects.

Hair analysis for drugs needs a better understanding of how drugs enter hair, considering factors like hair structure and pigmentation.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

New drug delivery methods can make natural compounds more effective and stable.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Nanotechnology improves minoxidil treatment for hair loss.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Rice bran extract might help prevent hair loss.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

HAT-L4 is crucial for preventing body fluid loss by maintaining skin barrier integrity.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.